ArticleFrontiers in pharmacology2023

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients.

Teerapat Majam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.